The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The Molecular Signatures Database Hallmark Gene Set Collection
Open accessAbstract
The Molecular Signatures Database (MSigDB) is one of the most widely used and comprehensive databases of gene sets for performing gene set enrichment analysis. Since its creation, MSigDB has grown beyond its roots in metabolic disease and cancer to include >10,000 gene sets. These better represent a wider range of biological processes and diseases, but the utility of the database is reduced by increased redundancy across, and heterogeneity within, gene sets. To address this challenge, here we use a combination of automated approaches and expert curation to develop a collection of "hallmark" gene sets as part of MSigDB. Each hallmark in this collection consists of a "refined" gene set, derived from multiple "founder" sets, that conveys a specific biological state or process and displays coherent expression. The hallmarks effectively summarize most of the relevant information of the original founder sets and, by reducing both variation and redundancy, provide more refined and concise inputs for gene set enrichment analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Performing gene set enrichment analysis using the MSigDB Hallmark gene sets (Liberzon et al. 2015), we observed that Myc target genes and DNA repair pathways were up-regulated, whereas TRP53 pathway genes were down-regulated (Fig. 4D).”
From Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging (2019) · cites this paper as Liberzon et al. 2015
The cited source says what the claim attributes to it.
In the citing paper
“Gene set enrichment analyses were performed according to standard procedures [39, 40] on two published RNA-seq datasets [31, 48]”
From A gene toolbox for monitoring autophagy transcription (2021) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“( F ) Hallmark gene set (81) enrichment plot for genes upregulated in control reactive astrocytes as compared to Ts21 reactive astrocytes (DEGs: adj. p<0.01, Wilcoxon Rank Sum test).”
From Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex (2026) · cites this paper as [81]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, carriers of MNAT1 gene, which is one of the leading genes in the G2/M checkpoint pathway58, were linked to better treatment outcome of FOLFOX54.”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredIn the citing paper
“Significant enrichment of hallmark gene sets (33) for inflammatory response and NF-κB signaling were found in the MDP-l,d dataset (Table S8).”
From Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy (2021) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationSystematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Self-citationVerhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Self-citationMolecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,112
Griffiths, J. I., Wallet, P., Pflieger, L. T., Stenehjem, D. D., Liu, X., Cosgrove, P. A., Leggett, N. A., McQuerry, J. A., Shrestha, G., Rossetti, M. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918937117 · Cited by 100
Tauopathy in the young autistic brain: novel biomarker and therapeutic target
Grigg, I., Ivashko‐Pachima, Y., Hait, T. A., Korenková, V., Touloumi, O., Lagoudaki, R., Dijck, A. V., Marušić, Z., Aničić, M., Vuković, J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00904-4 · Cited by 99
Harris, R. J. C., Cheung, A., Ng, J. C.-F., Laddach, R., Chenoweth, A. M., Crescioli, S., Fittall, M. W., Dominguez-Rodriguez, D., Roberts, J., Levi, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3773 · Cited by 100
Falcomatà, C., Bärthel, S., Widholz, S. A., Schneeweis, C., Montero, J. J., Toska, A., Mir, J., Kaltenbacher, T., Heetmeyer, J., Swietlik, J. J., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00326-1 · Cited by 103
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Capparelli, C., Purwin, T. J., Glasheen, M. Q., Caksa, S., Tiago, M., Wilski, N. A., Pomante, D., Rosenbaum, S. R., Nguyen, M. Q., Cai, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28801-y · Cited by 102
Integrated Multi-Omics Landscape of Liver Metastases
Yang, S., Qian, L., Li, Z., Li, Y., Bai, J., Zheng, B. J., Chen, K., Qiu, X., Cai, G., Wang, S., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.11.029 · Cited by 106
Novel insights from a multiomics dissection of the Hayflick limit
Chan, M., Yuan, H., Soifer, I., Maile, T. M., Wang, R. Y., Ireland, A., O'Brien, J. J., Goudeau, J., Chan, L. J., Vijay, T., et al. (2022) · eLife · doi:10.7554/elife.70283 · Cited by 99
“For gene set enrichment analysis, we downloaded the MSigDB Hallmark gene sets from misgDB website (version 7, gene symbols) Liberzon et al., 2015 .”
Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer
Morral, C., Stanisavljević, J., Hernando‐Momblona, X., Mereu, E., Álvarez-Varela, A., Cortina, C., Stork, D., Slebe, F., Turón, G., Whissell, G., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.04.012 · Cited by 102
Microenvironmental sensing by fibroblasts controls macrophage population size
Zhou, X., Franklin, R. A., Adler, M., Carter, T. S., Condiff, E., Adams, T. S., Pope, S. D., Philip, N. H., Meizlish, M. L., Kaminski, N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205360119 · Cited by 99
Bernstein, N., Chapman, M. S., Nyamondo, K., Chen, Z., Williams, N., Mitchell, E., Campbell, P. J., Cohen, R. L., & Nangalia, J. (2024) · Nature Genetics · doi:10.1038/s41588-024-01755-1 · Cited by 108
Zeng, D., Fang, Y., Qiu, W., Luo, P., Wang, S., Shen, R., Gu, W., Huang, X., Mao, Q., Wang, G., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100910 · Cited by 111
“The module also includes gene sets from Gene Ontology, 31 Kyoto Encyclopedia of Genes and Genomes, 32 HALLMARK, 33 and REACTOME databases, 34 allowing researchers to assess patients’ GEPs from various perspectives (Figure 1).”
InfluentialOwen, K. L., Gearing, L. J., Zanker, D. J., Brockwell, N. K., Khoo, W. H., Roden, D. L., Cmero, M., Mangiola, S., Hong, M. K. H., Spurling, A., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050162 · Cited by 101
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Kaliński, P., Endo, I., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12113342 · Cited by 97
Calcagno, D. M., Zhang, C., Toomu, A., Huang, K., Ninh, V. K., Miyamoto, S., Aguirre, A. D., Fu, Z., Brown, J. H., & King, K. R. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019019 · Cited by 99
Shi, R., Bao, X., Unger, K., Sun, J., Lu, S., Manapov, F., Wang, X., Belka, C., & Li, M. (2021) · Theranostics · doi:10.7150/thno.56202 · Cited by 98
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
Nouailles, G., Wyler, E., Pennitz, P., Postmus, D., Vladimirova, D., Kazmierski, J., Pott, F., Dietert, K., Mülleder, M., Farztdinov, V. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25030-7 · Cited by 90
IL-1β–driven osteoclastogenic Tregs accelerate bone erosion in arthritis
Levescot, A., Chang, M. H., Schnell, J. T., Nelson-Maney, N., Yan, J., Martínez‐Bonet, M., Grieshaber‐Bouyer, R., Lee, P. Y., Wei, K., Blaustein, R. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141008 · Cited by 100
Patient-specific Boolean models of signalling networks guide personalised treatments
Montagud, A., Béal, J., Tobalina, L., Traynard, P., Subramanian, V., Szalai, B., Alföldi, R., Puskás, L. G., Valencia, A., Barillot, E., et al. (2022) · eLife · doi:10.7554/elife.72626 · Cited by 98
B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection
Chen, S. T., Oliveira, T. Y., Gazumyan, A., Cipolla, M., & Nussenzweig, M. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.02.003 · Cited by 101
CDK8 Kinase Activity Promotes Glycolysis
Galbraith, M. D., Andrysík, Z., Pandey, A., Hoh, M., Bonner, E. A., Hill, A. A., Sullivan, K. D., & Espinosa, J. M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.058 · Cited by 103
Stergiakouli, E., Davey Smith, G., Martin, J., Skuse, D. H., Viechtbauer, W., Ring, S. M., Ronald, A., Evans, D. E., Fisher, S. E., Thapar, A., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0131-2 · Cited by 97
Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease
Rhee, S., Chung, J. I., King, D. A., D’Amato, G., Paik, D. T., Duan, A., Chang, A. H., Nagelberg, D., Sharma, B., Jeong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02796-3 · Cited by 98
Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes
Ye, I. C., Fertig, E. J., DiGiacomo, J. W., Considine, M., Godet, I., & Gilkes, D. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0345 · Cited by 96
Reske, J. J., Wilson, M. R., & Chandler, R. L. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00342-y · Cited by 100
FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs
Pittol, J. M. R., Milona, A., Morris, I., Willemsen, E. C. L., van der Veen, S. W., Kalkhoven, E., & van Mil, S. W. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.036 · Cited by 102
Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types
Sáez-Atiénzar, S., Bandrés‐Ciga, S., Langston, R. G., Kim, J. J., Choi, S. W., Reynolds, R. H., ITALSGEN, Abramzon, Y. A., Dewan, R., Ahmed, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd9036 · Cited by 95
Sebastiani, P., Federico, A., Morris, M., Gurinovich, A., Tanaka, T., Chandler, K. B., Andersen, S. L., Denis, G., Costello, C. E., Ferrucci, L., et al. (2021) · Aging Cell · doi:10.1111/acel.13290 · Cited by 103
Ding, J., Blencowe, M., Nghiem, T. X., Ha, S. M., Chen, Y.-W., Li, G., & Yang, X. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab405 · Cited by 99
Lam, K. H. B., Leon, A. J., Hui, W., Lee, S. C.-E. S., Batruch, I., Faust, K., Klekner, Á., Hutóczki, G., Koritzinsky, M., Richer, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27667-w · Cited by 97
Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications
Su, M., Pan, T., Chen, Q.-Z., Zhou, W., Gong, Y., Xu, G., Yan, H.-Y., Li, S., Shi, Q.-Z., Zhang, Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00434-8 · Cited by 114
Tian, Y., Xiao, H., Yang, Y., Zhang, P., Yuan, J., Zhang, W., Chen, L., Fan, Y., Zhang, J., Cheng, H., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01706-6 · Cited by 97
p53 governs an AT1 differentiation programme in lung cancer suppression
Kaiser, A. M., Gatto, A., Hanson, K. J., Zhao, R. L., Raj, N., Ozawa, M. G., Seoane, J. A., Bieging-Rolett, K. T., Wang, M., Li, I., et al. (2023) · Nature · doi:10.1038/s41586-023-06253-8 · Cited by 100
Li, H., Li, D., Ledru, N., Xuanyuan, Q., Wu, H., Asthana, A., Byers, L. N., Tullius, S. G., Orlando, G., Waikar, S. S., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.015 · Cited by 101
Xiong, D., Wang, Y., Singavi, A. K., Mackinnon, A. C., George, B., & You, M. (2018) · iScience · doi:10.1016/j.isci.2018.10.021 · Cited by 94
Rendeiro, A. F., Krausgruber, T., Fortelny, N., Zhao, F., Penz, T., Farlik, M., Schuster, L. C., Nemc, A., Tasnády, S., Réti, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14081-6 · Cited by 97
Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
Kim, E. Y., Ner‐Gaon, H., Varon, J., Cullen, A. M., Guo, J., Choi, J. E., Barragan-Bradford, D., Higuera, A., Pinilla-Vera, M., Short, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128075 · Cited by 98
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Kung, C.-P., Cottrell, K. A., Ryu, S., Bramel, E. R., Kladney, R. D., Bao, E. A., Freeman, E. C., Sabloak, T., Maggi, L. B., & Weber, J. D. (2020) · Oncogene · doi:10.1038/s41388-020-01515-5 · Cited by 98
Skwarski, M., McGowan, D. R., Belcher, E., Chiara, F., Stavroulias, D., McCole, M., Derham, J. L., Chu, K.-Y., Teoh, E., Chauhan, J. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4128 · Cited by 98
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication
Nilsson-Payant, B. E., Uhl, S. A., Grimont, A., Doane, A. S., Cohen, P., Patel, R. S., Higgins, C. A., Acklin, J. A., Bram, Y., Chandar, V., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01257-21 · Cited by 96
Ando, S., Perkins, C. M., Sajiki, Y., Chastain, C., Valanparambil, R. M., Wieland, A., Hudson, W. H., Hashimoto, M., Ramalingam, S. S., Freeman, G. J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160025 · Cited by 96
de Jong, F. C., Laajala, T. D., Hoedemaeker, R. F., Jordan, K. R., van der Made, A. C. J., Boevé, E. R., van der Schoot, D. K. E., Nieuwkamer, B. B., Janssen, E. A. M., Mahmoudi, T., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4118 · Cited by 97
Supervised discovery of interpretable gene programs from single-cell data
Kunes, R., Walle, T., Land, M., Nawy, T., & Pe’er, D. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01940-3 · Cited by 99
Pan-cancer proteogenomics characterization of tumor immunity
Petralia, F., Ma, W., Yaron, T. M., Caruso, F. P., Tignor, N. L., Wang, J. M., Charytonowicz, D., Johnson, J. L., Huntsman, E. M., Marino, G. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.027 · Cited by 104
Self-citationOliveira, M. F., Romero, J. P., Chung, M., Williams, S., Gottscho, A. D., Gupta, A., Pilipauskas, S. E., Mohabbat, S., Raman, N., Sukovich, D., et al. (2024) · doi:10.1101/2024.06.04.597233 · Cited by 95
Grunblatt, E., Wu, N., Zhang, H., Liu, X., Norton, J. P., Ohol, Y. M., Leger, P. R., Hiatt, J. B., Eastwood, E., Thomas, R., et al. (2020) · Genes & Development · doi:10.1101/gad.340133.120 · Cited by 93
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
Tanegashima, T., Togashi, Y., Azuma, K., Kawahara, A., Ideguchi, K., Sugiyama, D., Kinoshita, F., Akiba, J., Kashiwagi, E., Takeuchi, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3991 · Cited by 93
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
Randall, E. C., Lopez, B. G. C., Peng, S., Regan, M. S., Abdelmoula, W. M., Basu, S. S., Santagata, S., Yoon, H., Haigis, M. C., Agar, J. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0638 · Cited by 94
Poli‐Neto, O. B., Meola, J., Silva, J. C. R. E., & Tiezzi, D. G. (2020) · Scientific Reports · doi:10.1038/s41598-019-57207-y · Cited by 102
Yang, C., Tian, C., Hoffman, T. E., Jacobsen, N. K., & Spencer, S. L. (2021) · Nature Communications · doi:10.1038/s41467-021-21549-x · Cited by 101
JMJD3 activated hyaluronan synthesis drives muscle regeneration in an inflammatory environment
Nakka, K. K., Hachmer, S., Mokhtari, Z., Kovac, R., Bandukwala, H., Bernard, C., Li, Y., Xie, G., Liu, C., Fallahi, M., et al. (2022) · Science · doi:10.1126/science.abm9735 · Cited by 96
Multimodal deep learning approaches for single-cell multi-omics data integration
Athaya, T., Ripan, R. C., Li, X., & Hu, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad313 · Cited by 96
López-Polo, V., Maus, M., Zacharioudakis, E., Lafarga, M., Attolini, C. S., Marques, F. M., Kovatcheva, M., Gavathiotis, E., & Serrano, M. (2024) · Nature Communications · doi:10.1038/s41467-024-51363-0 · Cited by 101
Villarino, A. V., Sciumè, G., Davis, F. P., Iwata, S., Zitti, B., Robinson, G. W., Hennighausen, L. G., Kanno, Y., & O’Shea, J. J. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20150907 · Cited by 93
Cai, L., Liu, H., Huang, F., Fujimoto, J., Girard, L., Chen, J., Li, Y., Zhang, Y.-A., Deb, D., Stastny, V., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01842-7 · Cited by 93
Zeidner, J. F., Vincent, B. G., Ivanova, A., Moore, D. T., McKinnon, K. P., Wilkinson, A. D., Mukhopadhyay, R., Mazziotta, F., Knaus, H. A., Foster, M. C., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0070 · Cited by 94
Yu, L., Han, P., Chen, Y., Wang, H., Wang, S., Wang, M.-R., Liu, J., Yan, W., Tian, D., & Liu, M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.686 · Cited by 93
Shi, Y. X., Zhang, Q., Bi, H., Lu, M., Tan, Y., Zou, D., Ge, L., Chen, Z., Liu, C., Ci, W., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02651-9 · Cited by 94
Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment
Hoekstra, M. E., Slagter, M., Urbanus, J. H. M., Toebes, M., Slingerland, N., de Rink, I., Kluin, R. J. C., Nieuwland, M., Kerkhoven, R. M., Wessels, L. F. A., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.010 · Cited by 96
Mannion, J., Gifford, V., Bellenie, B. R., Fernando, W., Garcia, L. R., Wilson, R., John, S. W., Udainiya, S., Patin, E. C., Tiu, C., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.025 · Cited by 92
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Kakavand, H., Rawson, R. V., Pupo, G. M., Yang, J. Y. H., Menzies, A. M., Carlino, M. S., Kefford, R. F., Howle, J. R., Saw, R. P. M., Thompson, J. F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1688 · Cited by 96
Beane, J., Mazzilli, S. A., Campbell, J. D., Duclos, G. E., Krysan, K., Moy, C. H., Perdomo, C., Schäffer, M., Liu, G., Zhang, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09834-2 · Cited by 95
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Neto, J. M. F., Nadal, E., Bosdriesz, E., Ooft, S., Farré, L., McLean, C. M., Klarenbeek, S., Jurgens, A. P., Hagen, H., Wang, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16952-9 · Cited by 94
Gomez‐Aleza, C., Nguyen, B., Yoldi, G., Ciscar, M., Barranco, A., Hernández-Jiménez, E., Maetens, M., Salgado, R., Zafeiroglou, M., Pellegrini, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20138-8 · Cited by 92
Patsalos, A., Halász, L., Medina-Serpas, M. A., Berger, W. K., Dániel, B., Tzerpos, P., Kiss, M., Nagy, G., Fischer, C., Simándi, Z., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210420 · Cited by 94
Zwijnenburg, A. J., Pokharel, J., Varnaitė, R., Zheng, W., Hoffer, E., Shryki, I., Comet, N. R., Ehrström, M., Gredmark‐Russ, S., Eidsmo, L., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.025 · Cited by 92
A gene set enrichment analysis for cancer hallmarks
Menyhárt, O., Kothalawala, W. J., & Győrffy, B. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101065 · Cited by 92
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
Edwards, A. C., Stalnecker, C. A., Jean Morales, A., Taylor, K. E., Klomp, J. E., Klomp, J. A., Waters, A. M., Sudhakar, N., Hallin, J., Tang, T. T., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-2994 · Cited by 91
High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
Oh, S. A., Senger, K., Madireddi, S., Akhmetzyanova, I., Ishizuka, I. E., Tarighat, S., Lo, J. H., Shaw, D., Haley, B., & Rutz, S. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211530 · Cited by 88
Barrett, A. N., Fong, C., Subramanian, A., Liu, W., Feng, Y., Choolani, M. A., Biswas, A., Rajapakse, J. C., & Bongso, A. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0132 · Cited by 93
Meng, X., Duan, C., Pang, H., Chen, Q., Han, B. R., Zha, C., Dinislam, M., Wu, P., Li, Z., Zhao, S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.067 · Cited by 93
A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation
Tran, T. M., Guha, R., Portugal, S., Skinner, J., Ongoïba, A., Bhardwaj, J., Jones, M. B., Moebius, J., Venepally, P., Doumbo, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.009 · Cited by 91
Pepple, A., Guy, J., McGinnis, R. J., Felsted, A. E., Song, B., Hubbard, R. T., Worlikar, T., Garavaglia, H., Dib, J., Chao, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1012799 · Cited by 91
Zhang, A. M. Y., Xia, Y. H., Lin, J. S. H., Chu, K., Wang, W. C. K., Ruiter, T. J. J., Yang, J. C. C., Chen, N., Chhuor, J., Patil, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.003 · Cited by 91
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Bandres‐Ciga, S., Saez‐Atienzar, S., Bonet‐Ponce, L., Billingsley, K., Vitale, D., Blauwendraat, C., Gibbs, J. R., Pihlstrøm, L., Gan‐Or, Z., The International Parkinson's Disease Genomics Consortium (IPDGC), et al. (2019) · Movement Disorders · doi:10.1002/mds.27614 · Cited by 90
ADAR and Immune Silencing in Cancer
Herbert, A. G. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.03.004 · Cited by 90
Sirkisoon, S. R., Carpenter, R. L., Rimkus, T. K., Doheny, D. L., Zhu, D., Aguayo, N. R., Xing, F., Chan, M. D., Ruiz, J., Metheny‐Barlow, L. J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0959-3 · Cited by 90
de Jong, J. J., Liu, Y., Robertson, A. G., Seiler, R., Groeneveld, C. S., van der Heijden, M. S., Wright, J. L., Douglas, J., Dall’Era, M., Crabb, S. J., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0669-z · Cited by 90
Slowikowski, K., Nguyen, H. N., Noss, E. H., Simmons, D. P., Mizoguchi, F., Watts, G. F. M., Gurish, M. F., Brenner, M. B., & Raychaudhuri, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912702117 · Cited by 93
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors
Marschner, D., Falk, M., Jávorniczky, N. R., Hanke, K., Rawluk, J. K., Schmitt-Graeff, A. H., Simonetta, F., Haring, E., Dicks, S., Ku, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132334 · Cited by 90
TooManyCells identifies and visualizes relationships of single-cell clades
Schwartz, G. W., Zhou, Y., Petrovic, J., Fasolino, M., Xu, L., Shaffer, S. M., Pear, W. S., Vahedi, G., & Faryabi, R. B. (2020) · Nature Methods · doi:10.1038/s41592-020-0748-5 · Cited by 90
Wang, Y., Sangaré, L. O., Paredes-Santos, T. C., Hassan, M. A., Krishnamurthy, S., Furuta, A. M., Markus, B. M., Lourido, S., & Saeij, J. P. J. (2020) · Nature Communications · doi:10.1038/s41467-020-18991-8 · Cited by 87
Kim, S. Y., Zhang, X., Schiattarella, G. G., Altamirano, F. J., Ramos, T. A. R., French, K. M., Jiang, N., Szweda, P. A., Evers, B. M., May, H. I., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047239 · Cited by 90
Chen, X., Chen, H., Yao, H., Zhao, K., Zhang, Y., He, D., Zhu, Y., Cheng, Y., Liu, R., Xu, R., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02024-9 · Cited by 92
Annotation of cell types (ACT): a convenient web server for cell type annotation
Quan, F., Liang, X., Cheng, M., Yang, H., Liu, K., He, S., Sun, S., Deng, M., He, Y., Liu, W., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01249-5 · Cited by 93
Association ofMUC16Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors
Zhang, L., Han, X., & Shi, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13201 · Cited by 89
Friedrich, C., Schallenberg, S., Kirchner, M., Ziehm, M., Niquet, S., Haji, M., Beier, C., Neudecker, J., Klauschen, F., & Mertins, P. (2021) · Nature Communications · doi:10.1038/s41467-021-23855-w · Cited by 96
Zhang, F., Zhang, Q., Zhu, J., Yao, B., Ma, C., Qiao, N., He, S., Ye, Z., Wang, Y., Han, R., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00736-5 · Cited by 93
Mitotic clustering of pulverized chromosomes from micronuclei
Lin, Y.-F., Hu, Q., Mazzagatti, A., Valle-Inclán, J. E., Maurais, E. G., Dahiya, R., Guyer, A., Sanders, J. T., Engel, J. L., Nguyen, G., et al. (2023) · Nature · doi:10.1038/s41586-023-05974-0 · Cited by 87
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
Oikonomou, V., Smith, G., Constantine, G. M., Schmitt, M. M., Ferré, E. M. N., Alejo, J. C., Riley, D., Kumar, D., Dias, L. D. S., Pechacek, J., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312665 · Cited by 96
Schmeier, S., Alam, T., Essack, M., & Bajić, V. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1007 · Cited by 83
Profiling of the plasma proteome across different stages of human heart failure
Egerstedt, A., Berntsson, J., Smith, M. L., Gidlöf, O., Nilsson, R., Benson, M. D., Wells, Q. S., Celik, S., Lejonberg, C., Farrell, L. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13306-y · Cited by 96
Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
Simon, S. C. S., Hu, X., Panten, J., Grees, M., Renders, S., Thomas, D., Weber, R., Schulze, T. J., Utikal, J. S., & Umansky, V. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1727116 · Cited by 88
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Nagahashi, M., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186708 · Cited by 89
Song, K., Minami, J. K., Huang, A. J. Y., Dehkordi, S. R., Lomeli, S. H., Luebeck, J., Goodman, M. H., Moriceau, G., Krijgsman, O., Dharanipragada, P., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0936 · Cited by 85
Facile discovery of surrogate cytokine agonists
Yen, M., Ren, J., Liu, Q., Glassman, C. R., Sheahan, T. P., Picton, L. K., Moreira, F. R., Rustagi, A., Jude, K. M., Zhao, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.025 · Cited by 88
Kiani, K., Sanford, E. M., Goyal, Y., & Raj, A. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210979 · Cited by 82
Energy metabolism as therapeutic target for aged wound repair by engineered extracellular vesicle
Zhuang, Y., Jiang, S., Deng, X., Lao, A., Hua, X., Xie, Y., Jiang, L., Wang, X., & Lin, K. (2024) · Science Advances · doi:10.1126/sciadv.adl0372 · Cited by 91
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling
Rauner, M., Baschant, U., Roetto, A., Pellegrino, R. M., Rother, S., Salbach-Hirsch, J., Weidner, H., Hintze, V., Campbell, G., Petzold, A., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0005-8 · Cited by 87
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β–induced Serpine1
McCann, J. V., Xiao, L., Kim, D. J., Khan, O. F., Kowalski, P. S., Anderson, D. G., Pecot, C. V., Azam, S. H., Parker, J. S., Tsai, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123106 · Cited by 89
MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity
Peirsman, A., Blondeel, E., Ahmed, T., Anckaert, J., Audenaert, D., Boterberg, T., Buzás, K., Carragher, N. O., Castellani, G., Castro, F., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01291-4 · Cited by 94
Metadata
- Authors
- Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Mesirov, Jill P.
- Tamayo, Pablo
- Venue
- Cell Systems
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 1
- Issue
- 6
- Pages
- 417-425
- ISSN
- 2405-4712 (ISSN-L)
- PMC
- PMC4707969
- OpenAlex
- W2214074259
- Cited by
- 13,807
- References
- 37
- Citations by year
- 2026: 2174 · 2025: 2294 · 2024: 2415 · 2023: 1982 · 2022: 1708 · 2021: 1298 · 2020: 926 · 2019: 534 · 2018: 270 · 2017: 154 · 2016: 44
- FWCI
- 68.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Systems (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA154480, U54CA112962, R01CA121941)
- National Institute of General Medical Sciences (R01GM074024)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- Hallmark gene sets, gene set enrichment analysis, biological processes, cancer hallmarks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
